Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 791-794

  Kölsch, Heike ^a   Lütjohann, Dieter ^a   Jessen, Frank ^a   Von Bergmann, Klaus ^a   Schmitz, Sandra ^a   Urbach, Horst ^a   Maier, Wolfgang ^a   Heun, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

24S hydroxycholesterol; ABCA1; Alzheimer; Association; Cholesterol

Indexed keywords

24 HYDROXYCHOLESTEROL; 24-HYDROXYCHOLESTEROL; ABC TRANSPORTER; ABC TRANSPORTER A1; CHOLESTEROL; CHOLESTEROL DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYDROXYCHOLESTEROLS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33750591113     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.791     Document Type: Article

References (28)

1. Goate AM: Monogenetic determinants of Alzheimer's disease: APP mutations. Cell Mol Life Sci 54: 897-901, 1998.
2. Citron M, Westway D, Weiming X, et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72, 1997.
3. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS and Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981, 1993.
4. Myers A, Wavrant De Vrieze F, Holmans P, et al: Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114: 235-244, 2002.
5. Blacker D, Bertram L, Saunders AJ, et al: Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12: 23-32, 2003.
6. Notkola IL, Sulkava R, Pekkanen J, et al: Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 17: 14-20, 1998. (Pubitemid 28153361)
7. Kivipelto M, Helkala EL, Laakso MP, et al: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322: 1447-1451, 2001. (Pubitemid 32575406)
8. Kölsch H, Heun R, Kerksiek A, Bergmann KV, Maier W and Lütjohann D: Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci Lett 368: 303-308, 2004.
9. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, and Simons K: Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95: 6460-6464, 1998. (Pubitemid 28249035)
10. Fassbender K, Simons M, Bergmann C, et al: Simvastatin strongly reduces levels of Alzheimer's disease beta - amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98: 5856-5861, 2001.
11. Wolozin B, Kellman W, Ruosseau P, Celesia GG and Siegel G: Decreased prevalence of Alzheimer disease associated with 3- hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439-1443, 2000.
12. Jick H, Zornberg GL, Jick SS, Seshadri S and Drachman DA: Statins and the risk of dementia. Lancet 356: 1627-1631, 2000.
13. Probst MC, Thumann H, Aslanidis C, et al: Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis 175: 269-279, 2004. (Pubitemid 38942907)
14. Shioji K, Nishioka J, Naraba H, et al: A promoter variant of the ATP-binding cassette transporter A1 gene alters the HDL cholesterol level in the general Japanese population. J Hum Genet 49: 141-147, 2004.
15. Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A and Jensen GB: Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114: 1343-1353, 2004. (Pubitemid 40385306)
16. Clee SM, Zwinderman AH, Engert JC, et al: Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103: 1198-1205, 2001.
17. Cenarro A, Artieda M, Castillo S, et al: A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet 40: 163-168, 2003.
18. Katzov H, Chalmers K, Palmgren J, et al: Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23: 358-367, 2004.
19. Wollmer MA, Streffer JR, Lütjohann D, et al: ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 24: 421-426, 2003. (Pubitemid 36205049)
20. Li Y, Tacey K, Doil L, et al: Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366: 268-271, 2004.
21. World Health Organization: Composite International Diagnostic Interview. World Health Organization, Division of Mental Health, Geneva, 1999.
22. Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Morinigo A, and Mombour W: SIDAM - A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 21: 225-236, 1991.
23. Folstein MF, Folstein SE, and McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975.
24. Hixson JE and Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548, 1990.
25. Leoni V, Masterman T, Mousavi FS, et al: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med 42: 186-191, 2004. (Pubitemid 38401447)
26. Tan JH, Low PS, Tan YS, Tong MC, Saha N, Yang H and Heng CK: ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 113: 106-117, 2003.
27. Kyriakou T, Hodgkinson C, Pontefract DE, et al: Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol 25: 418-423, 2005.
28. Heinemeyer T, Wingender E, Reuter I, et al: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998.